Chronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary disease, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Hydroalcoholic extract of jujube and lemonbalm in the form of capsules 750 mg twice a day for 6 weeks. Intervention 2: Control group: placebo(Avisel) capsule for 6
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: People aged 40 to 70 with COPD, whose disease has been confirmed by a lung specialist COPD patients who did not have a known anxiety disorder and were not under standard psychiatric treatment, but had a score of 8 or higher based on the HADS questionnaire People who are satisfied with traditional treatment
Exclusion criteria
Exclusion criteria: Pregnancy and breastfeeding A history of severe anxiety that requires classical medical treatment People who are under the supervision of a psychiatrist or take psychiatric medication due to a known anxiety or mood disorder People who have severe anxiety in the screening tests will be referred to a psychiatrist for diagnostic evaluation and standard treatment Suffering from other medical diseases including hypothyroidism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety score in HADS anxiety subscale questionnaire. Timepoint: At the beginning of the study (before the intervention) and the 3rd and 6th week. Method of measurement: HADS anxiety subscale questionnaire.;Anxiety score in Spielberger's Clear and Hidden Anxiety Questionnaire (STAI). Timepoint: At the beginning of the study (before the intervention) and the 3rd and 6th week. Method of measurement: Spielberger state anxiety questionnaire.;CAT score. Timepoint: At the beginning of the study (before the intervention) and the 3rd and 6th week. Method of measurement: CAT test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Distance traveled in the 6MWT. Timepoint: At the beginning of the study (before the intervention) and the 3rd and 6th. Method of measurement: 6-minute walk test (6MWT).;Number of times sitting and getting up in the chair. Timepoint: At the beginning of the study (before the intervention) and the 3rd and 6th. Method of measurement: 1-min sit-to-stand test (STST).;Blood oxygen saturation (SaO2). Timepoint: At the beginning and end of each round of the (STST) and (6MWT). Method of measurement: Pulse oximeter device.;Pulse rate. Timepoint: At the beginning and end of each round of the (STST) and (6MWT). Method of measurement: Pulse oximeter device.;Quality of Life score on WHO Quality of Life Questionnaire (Bref-WHOQol). Timepoint: Before and after intervention. Method of measurement: WHO Quality of Life Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamane Mousapoor
Mashhad University of Medical Sciences
Outcome results
None listed